Select Medical Holdings Corporation (NYSE:SEM) was upgraded by research analysts at RBC Capital from a “sector perform” rating to an “outperform” rating in a report released on Monday,TheFlyOnTheWall.com reports. Select Medical Holdings Corporation (NYSE:SEM) stock performance was 1.91% in last session and finished the day at $13.88. Traded volume was 552,844.00million shares in the last session and the average volume of the stock remained 841.93K shares. The beta of the stock remained 1.03. Select Medical Holdings Corporation (NYSE:SEM) insider ownership is 12.00%.
Kindred Healthcare Inc (NYSE:KND) was upgraded by investment analysts at RBC Capital from a “sector perform” rating to an “outperform” rating in a note issued to investors on Monday,TheFlyOnTheWall.com reports. The firm currently has a $42.00 target price on the stock, up from their previous target price of $18.00. Kindred Healthcare, Inc. (NYSE:KND) rose 1.60 percent to $24.81 Wednesday on volume of 576,535.00million shares. The intra-day range of the stock was $24.45 to $24.97. Kindred Healthcare, Inc. (NYSE:KND) has a market capitalization of $1.36billion.
RadNet, Inc. (NASDAQ:RDNT) was a big mover last session, as the company saw its shares rise nearly 10% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. RadNet Inc. (NASDAQ:RDNT)’s stock on Apr 09, 2014 reported a increase of 0.97% to the closing price of $4.17. Its fifty two weeks range is $1.50 -$4.27. The total market capitalization recorded $171.44million. The overall volume in the last trading session was million shares. In its share capital, RDNT has 41.12million outstanding shares.
Specialty pharmaceuticals company Mallinckrodt Plc agreed to buy drugmaker Questcor Pharmaceuticals Inc (NASDAQ:QCOR) for about $5.6 billion to gain access to its multiple sclerosis drug, Acthar Gel. On Wednesday, shares of Questcor Pharmaceuticals Inc (NASDAQ:QCOR) advanced 5.46% to close the day at $85.16. Company return on investment (ROI) is 70.60% and its monthly performance is recorded as 34.09%. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) quarterly revenue growth is 69.57%.